Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines...
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, ...
Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines...
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet...
New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence
Medisafe, a leading digital drug companion company, announced the findings from two validation studies examining...
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine...
Fenbendazole dosage
The dosage of Fenbendazole depends upon the health condition of the patient, already prescribed medicines,...
Alvotech Initiates Clinical Studies for AVT04, A Proposed Biosimilar to Stelara
Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the...
Zydus applies to the DCGI for EUA to launch ZyCoV-D, the world’s first Plasmid...
Zydus Cadila announced that the company has applied for EUA to the office of Drug...
Menzies Cargo progresses with new CEIV Pharma accreditation
Menzies Aviation, the global aviation logistics specialist, is delighted to announce that its cargo operations...
